Neuronal mitophagy assays evaluate the selective degradation of damaged mitochondria in neurons, a process crucial for maintaining cellular homeostasis and preventing neurodegenerative diseases. These assays utilize markers such as PINK1 and Parkin to assess mitophagy activity, alongside mitochondrial membrane potential measurements and fluorescence-based detection methods. They are essential for studying mitochondrial dysfunction in neurological disorders and drug screening applications.
